House Bill No. 5616
Public Act No. 06-120
AN ACT CONCERNING SCREENING FOR KIDNEY DISEASE.
Be it enacted by the Senate and House of Representatives in General Assembly convened:
Section 1. (NEW) (Effective from passage) (a) As used in this section, "clinical laboratory" has the same meaning as provided in section 19a-30 of the general statutes, and "patient" does not include any person under eighteen years of age.
(b) Beginning September 1, 2006:
(1) Each physician licensed under chapter 370 of the general statutes shall order a serum creatinine test as part of each patient's annual physical examination if the patient has not submitted to such test within the one-year period preceding the annual physical examination. The order shall include a notification that the test is being ordered pursuant to the provisions of this subdivision.
(2) Each hospital licensed in this state shall order a serum creatinine test for each patient admitted to the hospital at least once during such patient's hospital stay. The order shall include a notification that the test is being ordered pursuant to the provisions of this subdivision.
(3) Any person, firm or corporation operating a clinical laboratory licensed in this state shall ensure that when the clinical laboratory tests a specimen to determine a patient's serum creatinine level, as ordered or prescribed by a physician or hospital pursuant to subdivision (1) or (2) of this subsection, the clinical laboratory shall (A) calculate the patient's estimated glomerular filtration rate using the patient's age and gender, which information shall be provided to the clinical laboratory by the physician or hospital, and (B) include the patient's estimated glomerular filtration rate with its report to the physician or hospital.
(4) A person, firm or corporation operating a clinical laboratory licensed in this state shall be deemed in compliance with subdivision (3) of this subsection if the clinical laboratory makes available to the ordering physician or hospital test order codes for serum creatinine that include eGFR.
Approved June 2, 2006